Metropolis Healthcare Share Price
Sector: Healthcare Facilities
You have to be logged in to add this to Watchlist.
Login or Register
2012.05 -4.90 (-0.24%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1990
Today’s High
2018.4
52 Week Low
1450.05
52 Week High
2306.85
2015.15 -5.55 (-0.27%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1988.15
Today’s High
2021.45
52 Week Low
1450
52 Week High
2318.3
Key Metrics
- Market Cap (In Cr) 10359.59
- Beta 0.7
- Div. Yield (%) 0
- P/B 9.44
- TTM P/E 75.87
- Peg Ratio -6.15
- Sector P/E 30.23
- D/E 0.16
- Open Price 2005.05
- Prev Close 2016.95
Metropolis Healthcare Analysis
Price Analysis
-
1 Week-6.22%
-
3 Months-3.4%
-
6 Month6.2%
-
YTD20.41%
-
1 Year23.13%
Risk Meter
- 26% Low risk
- 26% Moderate risk
- 26% Balanced Risk
- 26% High risk
- 26% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 3
- 3
- 3
- 3
- Buy
- 6
- 6
- 6
- 6
- Hold
- 1
- 1
- 1
- 1
- Sell
- 4
- 4
- 4
- 4
- Strong Sell
- 2
- 2
- 2
- 2
- Total
- 16
- 16
- 16
- 16
Metropolis Healthcare News
Dr. Lal Pathlabs, Info Edge India & others hit 52 week high today ; Do you own any?
3 min read . 04 Oct 2024Top Events of the Day: Aurobindo Pharma, Finolex Cables to post Q1 results; more
5 min read . 10 Aug 2024Stocks to buy: Heritage Foods, ONGC, among top four stock picks by SMC Global
4 min read . 09 Jul 2024Metropolis Healthcare Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 1207.71
- Selling/ General/ Admin Expenses Total
- 275.78
- Depreciation/ Amortization
- 94.47
- Other Operating Expenses Total
- 393.2
- Total Operating Expense
- 1019.6
- Operating Income
- 188.11
- Net Income Before Taxes
- 174.69
- Net Income
- 127.82
- Diluted Normalized EPS
- 24.87
- Period
- 2024
- Total Assets
- 1555.06
- Total Liabilities
- 458.91
- Total Equity
- 1096.16
- Tangible Book Valueper Share Common Eq
- 49.8
- Period
- 2024
- Cashfrom Operating Activities
- 264.07
- Cashfrom Investing Activities
- -89.41
- Cashfrom Financing Activities
- -181.2
- Net Changein Cash
- -6.21
- Period
- 2023
- Total Revenue
- 1148.21
- Selling/ General/ Admin Expenses Total
- 575.25
- Depreciation/ Amortization
- 89.22
- Other Operating Expenses Total
- 5.77
- Total Operating Expense
- 944.64
- Operating Income
- 203.57
- Net Income Before Taxes
- 187.5
- Net Income
- 142.88
- Diluted Normalized EPS
- 27.83
- Period
- 2023
- Total Assets
- 1501.61
- Total Liabilities
- 513.38
- Total Equity
- 988.23
- Tangible Book Valueper Share Common Eq
- 30.99
- Period
- 2023
- Cashfrom Operating Activities
- 247.09
- Cashfrom Investing Activities
- 46.79
- Cashfrom Financing Activities
- -292.33
- Net Changein Cash
- 2.85
- Period
- 2022
- Total Revenue
- 1228.34
- Selling/ General/ Admin Expenses Total
- 585.21
- Depreciation/ Amortization
- 63.22
- Other Operating Expenses Total
- 1.73
- Total Operating Expense
- 930.99
- Operating Income
- 297.35
- Net Income Before Taxes
- 293.35
- Net Income
- 214.18
- Diluted Normalized EPS
- 39.43
- Period
- 2022
- Total Assets
- 1530.29
- Total Liabilities
- 644.1
- Total Equity
- 886.2
- Tangible Book Valueper Share Common Eq
- 13.72
- Period
- 2022
- Cashfrom Operating Activities
- 253.27
- Cashfrom Investing Activities
- -737.57
- Cashfrom Financing Activities
- 162.52
- Net Changein Cash
- -323.14
- Period
- 2021
- Total Revenue
- 997.99
- Selling/ General/ Admin Expenses Total
- 436.9
- Depreciation/ Amortization
- 45.94
- Other Operating Expenses Total
- 2.62
- Total Operating Expense
- 755.08
- Operating Income
- 242.91
- Net Income Before Taxes
- 244.32
- Net Income
- 183.1
- Diluted Normalized EPS
- 35.79
- Period
- 2021
- Total Assets
- 1004.42
- Total Liabilities
- 297.81
- Total Equity
- 706.6
- Tangible Book Valueper Share Common Eq
- 113.83
- Period
- 2021
- Cashfrom Operating Activities
- 249.03
- Cashfrom Investing Activities
- 61.7
- Cashfrom Financing Activities
- -32.69
- Net Changein Cash
- 279.42
- Period
- 2020
- Total Revenue
- 856.41
- Selling/ General/ Admin Expenses Total
- 415.95
- Depreciation/ Amortization
- 39.27
- Other Operating Expenses Total
- 4.68
- Total Operating Expense
- 686.77
- Operating Income
- 169.63
- Net Income Before Taxes
- 168.73
- Net Income
- 127.33
- Diluted Normalized EPS
- 25.84
- Period
- 2020
- Total Assets
- 752.23
- Total Liabilities
- 228.74
- Total Equity
- 523.5
- Tangible Book Valueper Share Common Eq
- 79.99
- Period
- 2020
- Cashfrom Operating Activities
- 215
- Cashfrom Investing Activities
- -104.83
- Cashfrom Financing Activities
- -55.32
- Net Changein Cash
- 55.8
- Period
- 2019
- Total Revenue
- 761.18
- Selling/ General/ Admin Expenses Total
- 365.89
- Depreciation/ Amortization
- 20.07
- Other Operating Expenses Total
- 4.79
- Total Operating Expense
- 580.84
- Operating Income
- 180.34
- Net Income Before Taxes
- 186.55
- Net Income
- 120.15
- Diluted Normalized EPS
- 24.01
- Period
- 2019
- Total Assets
- 552.64
- Total Liabilities
- 134.1
- Total Equity
- 418.54
- Tangible Book Valueper Share Common Eq
- 63.1
- Period
- 2019
- Cashfrom Operating Activities
- 90.15
- Cashfrom Investing Activities
- 35.34
- Cashfrom Financing Activities
- -118.15
- Net Changein Cash
- 7.9
- Period
- 2018
- Total Revenue
- 647.16
- Selling/ General/ Admin Expenses Total
- 300.46
- Depreciation/ Amortization
- 19.02
- Other Operating Expenses Total
- 3.78
- Total Operating Expense
- 487.57
- Operating Income
- 159.59
- Net Income Before Taxes
- 163.68
- Net Income
- 104.24
- Diluted Normalized EPS
- 21.22
- Period
- 2018
- Total Assets
- 530.34
- Total Liabilities
- 115.57
- Total Equity
- 414.77
- Tangible Book Valueper Share Common Eq
- 63.7
- Period
- 2018
- Cashfrom Operating Activities
- 103.15
- Cashfrom Investing Activities
- 1.88
- Cashfrom Financing Activities
- -87.3
- Net Changein Cash
- 17.96
- Period
- 2024-09-30
- Total Revenue
- 349.79
- Selling/ General/ Admin Expenses Total
- 78.44
- Depreciation/ Amortization
- 26.82
- Other Operating Expenses Total
- 108.94
- Total Operating Expense
- 286.73
- Operating Income
- 63.06
- Net Income Before Taxes
- 61.4
- Net Income
- 46.52
- Diluted Normalized EPS
- 9.03
- Period
- 2024-09-30
- Total Assets
- 1631.23
- Total Liabilities
- 447.29
- Total Equity
- 1183.94
- Tangible Book Valueper Share Common Eq
- 67.72
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 122.47
- Cashfrom Investing Activities
- -98.62
- Cashfrom Financing Activities
- -41.91
- Net Changein Cash
- -18.23
- Period
- 2024-06-30
- Total Revenue
- 313.36
- Selling/ General/ Admin Expenses Total
- 71.69
- Depreciation/ Amortization
- 25.54
- Other Operating Expenses Total
- 97.04
- Total Operating Expense
- 260.08
- Operating Income
- 53.27
- Net Income Before Taxes
- 51.08
- Net Income
- 37.95
- Diluted Normalized EPS
- 7.37
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 331
- Selling/ General/ Admin Expenses Total
- 71.47
- Depreciation/ Amortization
- 26.42
- Other Operating Expenses Total
- 106.2
- Total Operating Expense
- 277.44
- Operating Income
- 53.56
- Net Income Before Taxes
- 50.53
- Net Income
- 36.41
- Diluted Normalized EPS
- 7.08
- Period
- 2024-03-31
- Total Assets
- 1555.06
- Total Liabilities
- 458.91
- Total Equity
- 1096.16
- Tangible Book Valueper Share Common Eq
- 49.8
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 264.07
- Cashfrom Investing Activities
- -89.41
- Cashfrom Financing Activities
- -181.2
- Net Changein Cash
- -6.21
- Period
- 2023-12-31
- Total Revenue
- 291.12
- Selling/ General/ Admin Expenses Total
- 69.51
- Depreciation/ Amortization
- 24.99
- Other Operating Expenses Total
- 97.42
- Total Operating Expense
- 251.26
- Operating Income
- 39.86
- Net Income Before Taxes
- 36.85
- Net Income
- 27.16
- Diluted Normalized EPS
- 5.28
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 308.5
- Selling/ General/ Admin Expenses Total
- 69.75
- Depreciation/ Amortization
- 22.24
- Other Operating Expenses Total
- 99.86
- Total Operating Expense
- 255.93
- Operating Income
- 52.57
- Net Income Before Taxes
- 48.11
- Net Income
- 35.45
- Diluted Normalized EPS
- 6.9
- Period
- 2023-09-30
- Total Assets
- 1509.14
- Total Liabilities
- 462.64
- Total Equity
- 1046.5
- Tangible Book Valueper Share Common Eq
- 41.95
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 108.59
- Cashfrom Investing Activities
- -48.06
- Cashfrom Financing Activities
- -73.55
- Net Changein Cash
- -17.9
- Period
- 2023-06-30
- Total Revenue
- 277.09
- Selling/ General/ Admin Expenses Total
- 65.06
- Depreciation/ Amortization
- 20.82
- Other Operating Expenses Total
- 89.71
- Total Operating Expense
- 234.97
- Operating Income
- 42.12
- Net Income Before Taxes
- 39.19
- Net Income
- 28.8
- Diluted Normalized EPS
- 5.62
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 282.55
- Selling/ General/ Admin Expenses Total
- 64.31
- Depreciation/ Amortization
- 23.43
- Other Operating Expenses Total
- 88.1
- Total Operating Expense
- 235.69
- Operating Income
- 46.85
- Net Income Before Taxes
- 41.9
- Net Income
- 33.36
- Diluted Normalized EPS
- 6.5
- Period
- 2023-03-31
- Total Assets
- 1501.61
- Total Liabilities
- 513.38
- Total Equity
- 988.23
- Tangible Book Valueper Share Common Eq
- 30.99
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 247.09
- Cashfrom Investing Activities
- 46.79
- Cashfrom Financing Activities
- -292.33
- Net Changein Cash
- 2.85
- Period
- 2022-12-31
- Total Revenue
- 285.46
- Selling/ General/ Admin Expenses Total
- 64.57
- Depreciation/ Amortization
- 23.03
- Other Operating Expenses Total
- 84.61
- Total Operating Expense
- 238
- Operating Income
- 47.46
- Net Income Before Taxes
- 47.97
- Net Income
- 35.8
- Diluted Normalized EPS
- 6.97
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Metropolis Healthcare Technical
Moving Average
SMA
- 5 Day2087.34
- 10 Day2110.57
- 20 Day2123.24
- 50 Day2169.43
- 100 Day2111.69
- 300 Day1942.8
Metropolis Healthcare Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Rainbow Childrens Medicare
- 1575.8
- -1.2
- -0.08
- 1685
- 1065.05
- 15994.69
- Vijaya Diagnostic Centre
- 1130.5
- 62.2
- 5.82
- 1136
- 580.75
- 11570.18
- Metropolis Healthcare
- 2012.05
- -4.9
- -0.24
- 2306.85
- 1450.05
- 10307.49
- Healthcare Global Enterprises
- 468.25
- -0.55
- -0.12
- 506.6
- 310.1
- 6522.24
- Kovai Medical Centre and Hospital
- 5273.35
- -62.55
- -1.17
- 5770
- 3050
- 5770.24
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Rainbow Childrens Medicare
- 74.05
- 12.73
- 19.88
- 13.8
- Vijaya Diagnostic Centre
- 92.15
- 16.64
- 22.14
- 21.2
- Metropolis Healthcare
- 81.25
- 9.44
- 20.59
- 14.66
- Healthcare Global Enterprises
- 143.37
- 7.89
- -4.88
- -3.5
- Kovai Medical Centre and Hospital
- 32.44
- 6.57
- 19.28
- 12.23
Metropolis Healthcare Shareholding
Shareholding Pattern
*Promoter pledging: 0.59%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 08-Nov-24
- Quarterly Results
- 10-Aug-24
- Quarterly Results
- 21-May-24
- Audited Results
- 02-Feb-24
- Quarterly Results
- 04-Nov-23
- Quarterly Results & Interim Dividend
- 02-Aug-23
- Quarterly Results
- 16-May-23
- Audited Results
- 10-Feb-23
- Quarterly Results & Interim Dividend
- 08-Nov-22
- Quarterly Results
- 10-Aug-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 21-Aug-24
- 31-Jul-24
- AGM
- 30-Oct-23
- 28-Sept-23
- POM
- 17-Aug-23
- 24-Jul-23
- AGM
- 11-Aug-21
- 05-Jul-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 06-Nov-23
- 17-Nov-23
- 17-Nov-23
- 4
- 07-Feb-23
- 23-Feb-23
- 23-Feb-23
- 8
- 03-Feb-22
- 22-Feb-22
- 21-Feb-22
- 8
- 04-Feb-21
- 19-Feb-21
- 17-Feb-21
- 8